<SEC-DOCUMENT>0001213900-26-039834.txt : 20260403
<SEC-HEADER>0001213900-26-039834.hdr.sgml : 20260403
<ACCEPTANCE-DATETIME>20260403124338
ACCESSION NUMBER:		0001213900-26-039834
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20260403
DATE AS OF CHANGE:		20260403
EFFECTIVENESS DATE:		20260403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MDxHealth SA
		CENTRAL INDEX KEY:			0001872529
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			C9

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294873
		FILM NUMBER:		26837373

	BUSINESS ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000
		BUSINESS PHONE:		949-271-9221

	MAIL ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MDx Health SA
		DATE OF NAME CHANGE:	20210713
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0284119-s8_mdxhealth.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As filed with the Securities and Exchange Commission
on April 3, 2026</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 5in">Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0px; margin-bottom: 0px; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0px auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OF 1933 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>MDXHEALTH SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 49%; font-weight: bold">Belgium</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center">Not Applicable</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">(State or other jurisdiction of <BR>
incorporation or organization)</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">(I.R.S. Employer<BR>
 Identification No.)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAP Business Center</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Zone Industrielle des Hauts-Sarts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>4040 Herstal, Belgium</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices) (Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>May 2017 Stock Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2019 Stock Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2021 Share Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2022 Share Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2023 Share Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2024 Share Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>2025 Share Option Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Full title of the plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Michael McGarrity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>MDxHealth, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>15279 Alton Parkway &mdash; Suite 100</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Irvine, CA 92618</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name and address of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>+1 949-812-6979</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Telephone number, including area code,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Mark Busch</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Patrick Rogers</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>K&amp;L Gates LLP</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>300 South Tryon Street</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Suite 1000</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Charlotte, North Carolina 28202</B>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Tel: (704) 331-7440</B>&nbsp;</P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Roel Meers<BR>
    Baker McKenzie BV/SRL</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Avenue du Boulevard 21</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1210 Brussels</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Belgium</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>+32 2 639 36 11</B>&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; width: 49%; text-align: left; text-indent: 0in">Large accelerated filer &#9744;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: left">Accelerated filer &#9744;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; text-align: left; text-indent: 0in">Non-accelerated filer &#9746;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Smaller reporting company &#9744;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.5in; text-align: left; text-indent: 0in"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Emerging growth company &#9746;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to
Section 7(a)(2)(B) of the Securities Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0px; margin-bottom: 0px; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Registration Statement on Form S-8 registers ordinary
shares issuable under the Registrant&rsquo;s May 2017 Stock Option Plan, dated June 19, 2017, 2019 Stock Option Plan, dated June 21, 2019,
2021 Share Option Plan, dated May 27, 2021, 2022 Share Option Plan, dated May 25, 2022, 2023 Share Option Plan, dated June 30, 2023, 2024
Share Option Plan, dated June 20, 2024, and 2025 Share Option Plan, dated June 27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The information required by this Part I is omitted
from this registration statement in accordance with Rule 428(b)(1) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
and the Note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the
participants in the plans covered by this Registration Statement as specified by&nbsp;Rule 428(b)(1) under the&nbsp;Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>Item 3.</B> <B>Incorporation of Documents by Reference. </B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following documents have been filed by MDxHealth
SA (the &ldquo;Registrant&rdquo;) with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) and are incorporated
herein by reference:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the Registrant&rsquo;s Annual Report on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1872529/000121390026039540/ea0283903-20f_mdxhealth.htm">Form 20-F</A> for the fiscal year ending December 31, 2025, filed with the Commission on April 3, 2026;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Registrant&rsquo;s Reports on Form 6-K furnished to the Commission on </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390026014925/ea0273599-6k_mdxhealth.htm"><FONT STYLE="font-size: 10pt"><U>February
11, 2026</U></FONT></A> <FONT STYLE="font-size: 10pt">and </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390026020775/ea02262026-6k_mdxhealth.htm"><FONT STYLE="font-size: 10pt"><U>February
26, 2026</U></FONT></A> <FONT STYLE="font-size: 10pt">(other than the information included in Exhibit 99.1 therein); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the description of our ordinary shares contained in&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1872529/000121390026039540/ea028390301ex2-1.htm">Exhibit 2.1</A>&nbsp;to our Annual Report on&nbsp;Form
20-F&nbsp;for the year ended December&nbsp;31, 2025, filed with the SEC on April 3, 2026, including any amendment or report filed
for the purpose of updating such description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">All reports and other documents filed by the Registrant
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof, and prior to the filing of a post-effective
amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold,
shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such reports and documents. The
Registrant is not incorporating by reference any reports or documents or portions thereof that are not considered to be &ldquo;filed&rdquo;
with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Any statement contained herein or in a document incorporated
or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement
to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated
herein by reference modifies or supersedes such earlier statement. Any statement so modified or superseded shall not be deemed, except
as so modified or superseded, to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0; text-indent: 0.5in">Information subsequently furnished on Form 6-K shall
not be deemed incorporated herein by reference unless such Form 6-K expressly provides to the contrary.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 4. Description of Securities</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 5. Interests of Named Experts and Counsel</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 6. Indemnification of Directors and Officers.</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Under Belgian law, the directors of a company may be
liable for damages to the company in case of improper performance of their duties. The Registrant's directors may be liable to the Registrant
and to third parties for infringement of the Registrant's articles of association or Belgian company law and, under certain circumstances,
pursuant to Belgian tort, bankruptcy, social security or tax laws. Under certain circumstances, directors may be criminally liable.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Registrant maintains liability insurance for the
Registrant's directors and officers, including insurance against liability under the Securities Act.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Belgian Companies and Associations Code includes
a cap on liability for directors (including persons in charge of daily management) for any damages they cause due to mismanagement, including
breaches of the articles of association and the Belgian Companies and Associations Code. This liability cap applies towards the company
and third parties. For the Registrant, the cap currently amounts to &euro;12,000,000.00 (subject to indexation). The cap applies irrespective
of the number of claimants or defendants for the same (set of) facts. However, the cap does not apply to repetitive minor misconduct,
serious error or cases of fraud or intent to harm. Furthermore, the cap does not apply to directors&rsquo; liability under the special
liability regimes relating to payment of withholding tax, VAT and social security contributions, and in certain other technical cases
provided for by the Belgian Companies and Associations Code.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0; text-indent: 0.5in">Certain of the Registrant&rsquo;s non-executive directors
may, through their relationships with their employers or partnerships, be insured and/or indemnified against certain liabilities in their
capacity as members of the Registrant&rsquo;s board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 7. Exemption from Registration Claimed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>Item 8.</B> <B>Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 10%">Exhibit <BR> Number</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; width: 88%">Description</TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>3.1</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1872529/000121390026039540/ea028390301ex1-1.htm">Articles of Association of MDxHealth SA (English Translation) (incorporated by reference to Exhibit 1.1 to the Registrant&rsquo;s Annual Report on Form 20-F filed on April 3, 2026)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD STYLE="width: 1in">3.2</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="http://www.sec.gov/Archives/edgar/data/1872529/000121390026039540/ea028390301ex1-2.htm">Corporate Governance Charter of MDxHealth SA (English Translation) (incorporated by reference to Exhibit 1.2 to the Registrant&rsquo;s Annual Report on Form 20-F filed on April 3, 2026)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>5.1</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify"><A HREF="ea028411901ex5-1.htm">Opinion of Baker McKenzie BV/SRL*</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>23.1</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="ea028411901ex23-1.htm">Consent of BDO R&eacute;viseurs d&rsquo;Entreprises SRL, Independent Registered Public Accounting Firm*</A></TD></TR>
<TR STYLE="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
<TD STYLE="text-align: left">23.2</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="ea028411901ex5-1.htm">Consent of Baker McKenzie BV/SRL (contained in Exhibit 5.1)*</A></TD>
</TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>24.1</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify"><A HREF="#KJ_001">Power of Attorney (included on the signature page of this Registration Statement)*</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>99.1</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390021052578/ff12021ex10-4_mdxhealthsa.htm">May 2017 Stock Option Plan (English Translation) (incorporated by reference to Exhibit 10.4 to the Registrant&rsquo;s Registration Statement on Form F-1 filed on October 13, 2021)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>99.2</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390021052578/ff12021ex10-5_mdxhealthsa.htm">2019 Stock Option Plan (English Translation) (incorporated by reference to Exhibit 10.5 to the Registrant&rsquo;s Registration Statement on Form F-1 filed on October 13, 2021)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>99.3</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390021052578/ff12021ex10-6_mdxhealthsa.htm">2021 Share Option Plan (English Translation) (incorporated by reference to Exhibit 10.6 to the Registrant&rsquo;s Registration Statement on Form F-1 filed on October 13, 2021)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>99.4</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390022022281/ea158919ex99-8_mdxhealth.htm">2022 Share Option Plan (English Translation) (incorporated by reference to Exhibit 99.8 to the Registrant&rsquo;s Report on Form 6-K filed on April 28, 2022)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>99.5</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390023032821/ea177486ex99-8_mdxhealth.htm">2023 Share Option Plan (English Translation) (incorporated by reference to Exhibit 99.8 to the Registrant&rsquo;s Report on Form 6-K filed on April 26, 2023)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>99.6</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390024043996/ea020616001ex99-8_mdxhealth.htm">2024 Share Option Plan (English Translation) (incorporated by reference to Exhibit 99.8 to the Registrant&rsquo;s Report on Form 6-K filed on May 16, 2024)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD>99.7</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: left"><A HREF="https://www.sec.gov/Archives/edgar/data/1872529/000121390025039137/ea024030901ex99-5_mdxhealth.htm">2025 Share Option Plan (English Translation) (incorporated by reference to Exhibit 99.5 to the Registrant&rsquo;s Report on Form 6-K filed on May 2, 2025)</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD>107</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify"><A HREF="ea028411901ex-fee.htm">Filing Fee Table*</A></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">*Filed herewith</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>Item 9. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The undersigned Registrant hereby undertakes:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: left">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">to include any prospectus required by section 10(a)(3) of the Securities Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: left">to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth
in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation
of Registration Fee&rdquo; table in the effective registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: left">to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration Statement;</TD></TR></TABLE>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0in"><U>provided</U>, <U>however</U>, that paragraphs
(a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange
Act that are incorporated by reference into this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: left">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: left">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: left">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the Registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: left">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion
of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="KJ_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left">Pursuant to the requirements of the Securities Act,
the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine,
California, on April 3, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">MDxHealth SA</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Michael McGarrity&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Michael McGarrity</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer and Director</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Principal Executive Officer)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 9pt 0 3.25in; text-align: center; text-indent: -3.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 9pt 0 3.25in; text-align: center; text-indent: -3.25in"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 9pt 0 3.25in; text-align: center; text-indent: -3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Each person whose signature appears
below constitutes and appoints Michael McGarrity and Joseph Sollee, and each of them, his/her true and lawful attorney-in-fact and agent,
each of whom may act alone, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any
and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and
to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he/she might or could do in person,
hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof. This power of attorney may be executed in counterparts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Pursuant to the requirements of
the Securities Act, this Registration Statement has been signed below by the following persons in the capacities indicated, in each case
on April 3, 2026:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: top; width: 40%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: top; width: 40%"><B>Signature/<FONT STYLE="font-size: 10pt">Title</FONT></B></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Michael McGarrity</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Michael McGarrity</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">Chief Executive Officer and Director (Principal Executive Officer)</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Ron Kalfus</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Ron Kalfus</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">Interim Chief Financial Officer (Principal Financial and Accounting Officer)</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Koen Hoffman</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Koen Hoffman (acting through Ahok BV)</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Dr. Sanford Jay Siegel</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dr. Sanford Jay Siegel&nbsp;&nbsp;</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Hilde Windels</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Hilde Windels (acting through Hilde Windels BV)</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Michael Holder</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Michael Holder</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Dr. Eric Bednarski</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dr. Eric Bednarski</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Dated: April 3, 2026</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Donnie (Don) M. Hardison</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Donnie (Don) M. Hardison</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE OF AUTHORIZED US REPRESENTATIVE OF REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Act
of 1933, as amended, the undersigned, the duly authorized representative in the United States of MDxHealth SA, has signed this registration
statement on Form S-8&nbsp;on&nbsp;April 3, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>MDxHealth, Inc.</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Michael McGarrity&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Michael McGarrity</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea028411901ex5-1.htm
<DESCRIPTION>OPINION OF BAKER MCKENZIE BV/SRL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="8" STYLE="width: 50%; font-size: 10pt; font-weight: bold"><IMG SRC="ex028411901_ex5-1img1.jpg" ALT="" STYLE="height: 68pt; width: 193.2pt"></TD>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold">Baker McKenzie BV/SRL</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Bolwerklaan 21 Avenue du Boulevard - box 1</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">1210 Brussels</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Belgium</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Tel: +32 2 639 36 11</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Fax: +32 2 639 36 99</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">www.bakermckenzie.com</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">April 3, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">MDxHealth SA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">CAP Business Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Zone Industrielle des Hauts-Sarts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rue d&rsquo;Abhooz 31</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4040 Herstal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Belgium</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dear all,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.25pt; text-align: justify; text-indent: -35.25pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.25pt"><B>RE:</B></TD><TD STYLE="text-align: justify"><B>MDXHEALTH SA &ndash; ISSUANCE OF SHARES</B></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">1.</TD><TD STYLE="text-align: justify">Introduction</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: left">We have acted as external Belgian law counsel to MDxHealth SA of CAP Business Center, Zone Industrielle
des Hauts-Sarts, Rue d&rsquo;Abhooz 31, 4040 Herstal, Belgium, registered under company number 0479.292.440 RLP Li&egrave;ge (division Li&egrave;ge)
(the &ldquo;<B>Company</B>&rdquo;), on certain Belgian law matters in connection with the Company&rsquo;s the Registration Statement (as defined
below) filed with the United States Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) under the United States Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), in respect of the potential issuance by the Company of new ordinary shares
without nominal value of the Company (the &ldquo;<B>New Shares</B>&rdquo;)<FONT STYLE="background-color: white">, with admission to trading
and listing of the New Shares on the Nasdaq Capital Market, covered by the Registration Statement to which this opinion is an exhibit,</FONT>
such New Shares to be issued upon exercise of the following outstanding share options in the form of subscription rights (collectively,
the &ldquo;<B>Share Options</B>&rdquo;, and such potential issuance of New Shares upon exercise of the respective Share Options the &ldquo;<B>Potential
Issuance</B>&rdquo;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on June 19, 2017 (the &ldquo;<B>2017
Share Options</B>&rdquo;),</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on June 21, 2019 (the &ldquo;<B>2019
Share Options</B>&rdquo;),</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on May 27, 2021 (the &ldquo;<B>2021
Share Options</B>&rdquo;),</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; padding-right: 2.15pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><B>Partners</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Koen VANHAERENTS<SUP>1*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Jean-Fran&ccedil;ois VANDENBERGHE<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Roel MEERS<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Luc MEEUS<SUP>1,5,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Fiona CARLIN<SUP>1,3,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Kurt HAEGEMAN<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Dominique MAES<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Michael VAN ACKER<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">G&eacute;ry BOMBEKE<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Elisabeth DEHARENG<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Geert BOVY<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Gavin BUSHELL<SUP>1,4,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Gregory LEBRUN<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Dimitri VAN UYTVANCK<SUP>1,9*</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P></TD>
    <TD STYLE="width: 19%; padding-right: 2.15pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Davinia MARTENS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Julie PERMEKE<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Joren JANSSEUNE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Arne NAERT<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">David HAVERBEKE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Wouter VANDORPE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><B>Senior Counsels &amp; Counsels</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Jozef SLOOTMANS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Alain HUYGHE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Philippe LION<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">St&eacute;phane MARTIN<SUP>9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Olivier VAN BAELEN<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Els JANSSENS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Kim STAS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Bram HOORELBEKE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P></TD>
    <TD STYLE="width: 19%; padding-right: 2.15pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Veerle LERUT<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Benjamin PIRLET<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">J&eacute;r&ocirc;me DE RUYVER<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Sebastian TYTGAT<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Nastassja WALSCHOT<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">William-James KETTLEWELL<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Ellen DEVLOO<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Pieter-Jan DENYS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Kristoff COX<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Lisa WEINERT<SUP>7,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Nicolas CELIS<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><B>Associates</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Mario DEKETELAERE<SUP>2</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Olivier VAN DEN BROEKE<SUP>2,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Lien WILLEMS<SUP>1,9</SUP>&nbsp;</FONT></P></TD>
    <TD STYLE="width: 19%; padding-right: 2.15pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Ellen HERINCKX<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Laura DECLERCQ<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Amaranta RUTZ<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Younes SEBBARH<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Eva CLAEYS<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">St&eacute;phanie DE POTTER<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Anne-Sophie CORNE<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">In&egrave;s SILVESTRINI<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Arnaud FLAMAND<SUP>1,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Cl&eacute;mence ROUMA<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Eline KEGELS<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Stephanie VAN LAETHEM<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Anne-Marie G&Uuml;LGER<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Caroline MOUCHET<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Caroline SERBANESCU<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P></TD>
    <TD STYLE="width: 19%; padding-right: 2.15pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Katia DEHON<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Rapha&euml;l HENDRICKX<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Dieter GEUENS<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Tim MEYNEN<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Guillian BACLIN<SUP>1</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Alexandra STOICA<SUP>2,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><B>Associated with the Brussels Bar</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">E-List</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Victor SAINT-CAST<SUP>7</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">B-List</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Tom JENKINS<SUP>4,8,9</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt">Roma MCCOOL<SUP>4</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 8pt"><SUP>&nbsp;</SUP></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0"><FONT STYLE="font-size: 8pt">1 &ndash; <B>Advocaat
/ Avocat</B>, Member of the Brussels Bar | 2 &ndash; <B>Advocaat</B>, Member of the Antwerp Bar | 3 &ndash; <B>Barrister</B>, Inn of
Court, Northern Ireland | 4 &ndash; <B>Solicitor</B> (England and Wales) | 5 &ndash; <B>Attorney</B>, Member of the New York Bar | 6
&ndash; <B>Rechtsanwalt</B>, Member of the D&uuml;sseldorf Bar | 7 &ndash; <B>Avocat</B>, Member of the Lille Bar | 8 &ndash; <B>Solicitor</B>
of the High Court of Hong Kong | 9 &ndash; BV/SRL | * &ndash; Shareholder/Director of Baker McKenzie BV/SRL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iv)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on May 25, 2022 (the &ldquo;<B>2022
Share Options</B>&rdquo;),</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(v)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on June 30, 2023 (the &ldquo;<B>2023
Share Options</B>&rdquo;),</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(vi)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on June 20, 2024 (the &ldquo;<B>2024
Share Options</B>&rdquo;), and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(vii)</TD><TD STYLE="text-align: justify">share options in the form of subscription rights issued by the Company on June 27, 2025 (the &ldquo;<B>2025
Share Options</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: justify">For the purposes of this opinion letter (the &ldquo;<B>Opinion Letter</B>&rdquo;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">we have reviewed only the documents referred to in paragraph 3 (Documents Reviewed); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">we have completed only the searches and enquiries referred to in paragraph&nbsp;4 (Searches and Enquiries);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.6pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.6pt; text-align: left">and we have not examined any other documents
relating to or affecting, and have not made any other searches or enquiries regarding the Company or any of the persons to whom Share
Options have been granted and other holders of Share Options (each such person or holder a &ldquo;<B>Share Option Holder</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">Nothing in this Opinion Letter should be construed as implying that we are familiar with, or have made
independent review or investigation of factual matters such as, the affairs of the Company or any of the Share Option Holders, and this
Opinion Letter is based solely on the investigations and subject to the limits stated in this Opinion Letter. We do not assume any responsibility
for advising you of the (subsequent) discovery of information not previously known to us with respect to any matters described in this
Opinion Letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(d)</TD><TD STYLE="text-align: left">The opinion in this Opinion Letter is limited to the matters stated herein and does not extend to, and
is not to be read as extending by implication to, any other matter in connection with the Potential Issuance, the Share Options, or otherwise.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">2.</TD><TD STYLE="text-align: justify">Belgian Law Opinion</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: left">This Opinion Letter is limited to matters of Belgian law as in force, and as construed in published Belgian
case law, as at the date of this Opinion Letter. Consequently:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: left">we have made no investigation of foreign law, and do not express or imply any opinion on foreign law (including,
but not limited to, the laws of the United States of America) or on European Union law as it affects any jurisdiction other than Belgium;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: left">we do not assume any responsibility for advising you of any changes in law or otherwise after the date
of this Opinion Letter with respect to any matters described in this Opinion Letter; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: left">we express no opinion on matters of taxation, matters of antitrust and competition, matters of fact or
matters of accounting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.6pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.6pt; text-align: justify; text-indent: -35.3pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.6pt; text-align: justify; text-indent: -35.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.9pt"></TD><TD STYLE="width: 35pt">(b)</TD><TD STYLE="text-align: left">As Belgian law counsel we are not qualified or able to assess the true meaning and purport of the terms
or any agreements, documents and legal acts (rechtshandelingen / actes juridiques) subject or expressed to be subject to any applicable
law other than Belgian law, including, but not limited to, the Registration Statement, and we have made no investigation of such meaning
and purport. Our review of agreements, documents or legal acts (rechtshandelingen / actes juridiques) subject or expressed to be subject
to any law other than Belgian law, including, but not limited to, the Registration Statement has therefore been limited to the terms of
such documents as they appear to us on their face.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">We do not admit we are &ldquo;<I>experts</I>&rdquo; within the meaning of the Securities Act, or the rules
and regulations of the SEC promulgated thereunder, with respect to any part of the Registration Statement or otherwise.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">3.</TD><TD STYLE="text-align: justify">Documents Reviewed</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">For the purposes of this Opinion Letter
we have examined the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: left">an electronic version of a copy of the Company&rsquo;s registration statement on Form S-8 relating to the New
Shares, to be filed with the SEC (the registration statement at the time it becomes effective, including all information deemed to be
a part thereof, including the amendments, exhibits and schedules thereto, at the time such registration statement becomes effective, is
herein referred to as the &ldquo;<B>Registration Statement</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: left">an excerpt of the deed of incorporation of the Company as published in the Annexes to the Belgian Official
Gazette on January 23, 2003 (the &ldquo;<B>Deed of Incorporation</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">an electronic version of a copy of the amended and restated articles of association of the Company as
filed in the legal entity file (<I>dossier van de rechtspersoon/dossier de la personne morale</I>) on October 20, 2025, electronically
certified by the Royal Federation of Belgian Notaries (<I>Koninklijke Federatie van het Belgisch Notariaat/F&eacute;d&eacute;ration Royale
du Notariat Belge</I>) on April 1, 2026, (as available through the Fednot Database (as defined below));</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(d)</TD><TD STYLE="text-align: justify">an electronic version of a signed copy of the following documents:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: left">in relation to the 2017 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on June 19, 2017 in relation to, amongst other things, the issuance of the 2017 Share Options and the approval of
the terms and conditions of the 2017 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance
with articles 583, 596 and 598 of the old Belgian Companies Code, and the report of the statutory auditor of the Company, prepared in
accordance with articles 596 and 598 of the old Belgian Companies Code, each of the aforementioned reports as submitted to the extraordinary
general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(i);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.35pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: left">in relation to the 2019 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on June 21, 2019 in relation to, amongst other things, the issuance of the 2019 Share Options and the approval of
the terms and conditions of the 2019 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance
with articles 583, 596 and 598 of the old Belgian Companies Code, and the report of the statutory auditor of the Company, prepared in
accordance with articles 596 and 598 of the old Belgian Companies Code, each of the aforementioned reports as submitted to the extraordinary
general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(ii);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: left">in relation to the 2021 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on May 27, 2021 in relation to, amongst other things, the issuance of the 2021 Share Options and the approval of the
terms and conditions of the 2021 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance with
articles 7:180 and 7:191 of the Belgian Companies and Associations Code, and the report of the statutory auditor of the Company, prepared
in accordance with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, each of the aforementioned reports as submitted
to the extraordinary general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(iii);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iv)</TD><TD STYLE="text-align: left">in relation to the 2022 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on May 25, 2022 in relation to, amongst other things, the issuance of the 2022 Share Options and the approval of the
terms and conditions of the 2022 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance with
articles 7:180 and 7:191 of the Belgian Companies and Associations Code, and the report of the statutory auditor of the Company, prepared
in accordance with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, each of the aforementioned reports as submitted
to the extraordinary general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(iv);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(v)</TD><TD STYLE="text-align: left">in relation to the 2023 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on June 30, 2023 in relation to, amongst other things, the issuance of the 2023 Share Options and the approval of
the terms and conditions of the 2023 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance
with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, and the report of the statutory auditor of the Company,
prepared in accordance with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, each of the aforementioned reports
as submitted to the extraordinary general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(v);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(vi)</TD><TD STYLE="text-align: left">in relation to the 2024 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on June 20, 2024 in relation to, amongst other things, the issuance of the 2024 Share Options and the approval of
the terms and conditions of the 2024 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance
with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, and the report of the statutory auditor of the Company,
prepared in accordance with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, each of the aforementioned reports
as submitted to the extraordinary general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(vi); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.35pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.35pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.35pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(vii)</TD><TD STYLE="text-align: left">in relation to the 2025 Share Options: (A) the minutes of the extraordinary general shareholders&rsquo; meeting
of the Company held on June 27, 2025 in relation to, amongst other things, the issuance of the 2025 Share Options and the approval of
the terms and conditions of the 2025 Share Options, and (B) the report of the board of directors of the Company, prepared in accordance
with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, and the report of the statutory auditor of the Company,
prepared in accordance with articles 7:180 and 7:191 of the Belgian Companies and Associations Code, each of the aforementioned reports
as submitted to the extraordinary general shareholders&rsquo; meeting of the Company referred to in this paragraph 3(d)(vii).</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">4.</TD><TD STYLE="text-align: justify">Searches and Enquiries</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">We have carried out the following searches
and enquiries using the registration number of the Company with the Crossroads Bank for Enterprises as it appears in this Opinion Letter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: left">we obtained a &ldquo;<I>full extract
of the details of a registered entity (legal person)</I>&rdquo; issued by the Crossroads Bank of Enterprises in relation to the Company
and referring to the circumstances in existence on March 30, 2026 (the &ldquo;<B>CBE Excerpt</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: left">on March 30, 2026, we carried out an on-line search in the Central Insolvency Register available on www.regsol.be
(the &ldquo;<B>Regsol Search</B>&rdquo;) in relation to the Company which did not show any bankruptcy, public judicial reorganisation or
transfer under judicial authority files opened in respect of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">on March 30, 2026, we carried out an on-line search and review of the Annexes to the Belgian Official
Gazette relating to the Company up to six years prior to the date of this Opinion Letter (the &ldquo;<B>Publications</B>&rdquo;). The
most recent publication available in the Annexes to the Belgian Official Gazette was publication number 25364751 dated October 22, 2025.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">5.</TD><TD STYLE="text-align: justify">Assumptions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">For the purposes of this Opinion Letter,
we have assumed (without making any investigation) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(a)</TD><TD STYLE="text-align: justify">all copy documents reviewed by us conform to the originals, and all originals are genuine, complete and
up-to-date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(b)</TD><TD STYLE="text-align: justify">all signatures, stamps and seals on any documents submitted to us are genuine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">the executed documents submitted to us have been signed by the persons whose names are indicated thereon
as being the names of the signatories and we have assumed the legal capacity (<I>bekwaamheid/capacit&eacute;</I>) of the natural persons
executing such documents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(d)</TD><TD STYLE="text-align: left">in the case of draft versions or (or draft updates to) any of the documents reviewed by us, the final
and executed versions of such documents are identical in all aspects to such drafts and are duly executed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(e)</TD><TD STYLE="text-align: justify">the Registration Statement will become effective and will be filed in the form referred to in this Opinion
Letter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(f)</TD><TD STYLE="text-align: left">the Publications give a true, complete and not misleading summary of the matters reflected in the documents
on which such excerpts are based and such matters have not been revoked or amended by subsequent decisions by the Company (or its board
of directors, general shareholders&rsquo; meeting, or any of its other competent bodies or representatives) which were not published in the
Annexes to the Belgian Official Gazette;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(g)</TD><TD STYLE="text-align: left">there have been, and there will be, no amendments or supplements to the documents referred to under paragraph
3 (Documents Reviewed) in the form as examined by us, such documents (or the matters documented therein and thereby) have not been or
will not be terminated, rescinded, declared null and void, or revoked, and there are no and will not be dealings, agreements or arrangements,
actions or events between, by or involving any of the parties to such documents which supersede any of such documents (or the matters
documented therein and thereby), or which otherwise affect the opinion given in this Opinion Letter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(h)</TD><TD STYLE="text-align: left">the Deed of Incorporation of the Company refers to a valid notary deed, of which the contents are complete
and accurate, and which is not void or otherwise affected by any defects for which a court might dissolve the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(i)</TD><TD STYLE="text-align: left">the seat (<I>zetel/si&egrave;ge</I>) of the Company is located in Belgium since its incorporation, and
the Company&rsquo;s sole operational headquarters (<I>exploitatiezetel/si&egrave;ge d&rsquo;exploitation</I>) are located at the place of its registered
office;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(j)</TD><TD STYLE="text-align: left">the articles of association of the Company have not been amended since the restatement referred to in
paragraph 3(c), and accurately restate the original articles of association and the subsequent amendments thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(k)</TD><TD STYLE="text-align: left">(i)&nbsp;the board reports referred to under paragraph 3 (Documents Reviewed) above and the granting of
the Share Options have been approved by duly appointed directors in accordance with the Company&rsquo;s articles of association and Belgian
law, (ii)&nbsp;the respective directors of the Company who passed such approval complied with the applicable provisions of, as relevant,
article 523 of the old Belgian Companies Code or article 7:96 of the Belgian Companies and Associations Code (as well as article 1.8,
&sect;6 of the Belgian Civil Code) dealing with conflicts of interest of directors (as the case may be), (iii) insofar as needed and applicable,
the respective directors of the Company who passed such approval complied with the applicable provisions of, as relevant, article 524
of the Belgian Companies Code or article 7:97 of the Belgian Companies and Associations Code dealing with related party transactions (as
the case may be), and (iv)&nbsp;such approvals have not been amended, revoked, varied or declared null and void, and remain in full force
and effect;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(l)</TD><TD STYLE="text-align: left">each of the resolutions of the general shareholders&rsquo; meetings of the Company referred to, set out or implied
in the documents referred to under paragraph 3 (Documents Reviewed) above (i) accurately record resolutions that were duly passed at a
properly convened and quorate meeting of genuine shareholders of the Company, conducted in accordance with its articles of association
and Belgian law and on the basis of reports of the board of directors (as applicable) duly approved by duly appointed directors, (ii)
do not reflect any untruthful statements, and (iii) have not been amended, revoked, varied or declared null and void, and remain in full
force and effect;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(m)</TD><TD STYLE="text-align: left">the directors of the Company have satisfied themselves that the Share Options were issued and granted
for the purpose of carrying out the business of the Company as set out in its articles of association, and that the issuance and grant
of the Share Options are of benefit to the Company, and their conclusions in this respect are not unreasonable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="text-align: left; break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: left; margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(n)</TD><TD STYLE="text-align: left">with respect to each Share Option Holder:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(i)</TD><TD STYLE="text-align: left">in case of a legal entity, it has been duly incorporated and is validly existing as a legal entity under
all laws applicable to that Share Option Holder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: left">it has all requisite power and capacity (corporate and otherwise) and has all requisite corporate benefit,
in each case as relevant, to subscribe for, hold and exercise the Share Options that it holds, and to perform its obligations thereunder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(iii)</TD><TD STYLE="text-align: left">no other action by, and no notice to or filing with, any governmental, administrative or other authority
or court on behalf of or by such party is required in order to enable it (as relevant) to validly subscribe for, hold and exercise the
Share Options that it holds;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(iv)</TD><TD STYLE="text-align: left">(as relevant) it has duly authorised and approved the subscription, holding and exercise of the Share
Options that it holds;&nbsp;and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(v)</TD><TD STYLE="text-align: left">(as relevant) each of the agreements to which it is a party in connection with the subscription for or
acquisition of Share Options constitutes a valid and binding agreement or undertaking of said Share Option Holder, enforceable against
it in accordance with the terms and conditions of such Share Options;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(o)</TD><TD STYLE="text-align: left">none of the Share Option Holders or the Company is or will be subject to any contractual restrictions,
restrictions imposed by any court, arbitral panel or governmental, administrative or other authority that do not have general (<I>erga
omnes</I>) application or similar restrictions binding upon it which would (i) restrict its ability to enter into, assume or perform its
obligations under the Share Options (except, in relation to the Company, as may be set out in its articles of association), or (ii) have
any implication on the opinion given in this Opinion Letter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(p)</TD><TD STYLE="text-align: left">none of the Share Option Holders has:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(i)</TD><TD STYLE="text-align: left">resolved to enter into liquidation, been dissolved, been annulled as a legal entity, filed an application
for or been subject to proceedings for judicial reorganisation, filed an application for bankruptcy or been declared bankrupt; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 106.3pt; text-align: left; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 70.9pt"></TD><TD STYLE="text-align: left; width: 35.4pt">(ii)</TD><TD STYLE="text-align: left">ceased to pay its debts as they fall due or is subject to measures such as the appointment of a provisional
administrator or the sequestration of assets,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: 0in">and none of them has
taken, or become subject to, similar proceedings or measures in any applicable jurisdiction ;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(q)</TD><TD STYLE="text-align: left">each of the Share Option Holders and the Company has complied, and will continue to comply, with the requirements
of good faith (<I>goede trouw/bonne foi</I>) and public policy (<I>openbare orde/ordre public</I>), and there has been and will be no
mistake of fact (<I>dwaling/erreur</I>), fraud (<I>bedrog/dol</I>), duress (<I>geweld/violence</I>), or abuse of circumstances (<I>misbruik
van omstandigheden/abus de circonstances</I>) in relation to the Share Options;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(r)</TD><TD STYLE="text-align: left">none of the Share Option Holders or the Company is or will be seeking to achieve any purpose not apparent
from (as relevant) the Share Options which might render the Share Options illegal or void, and the Share Options have been or will be
issued and acquired (as relevant), for bona fide commercial reasons and on arms&rsquo; length terms by each of the parties thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(s)</TD><TD STYLE="text-align: left">the obligations of Share Option Holders or the Company under the Share Options are or will be binding
and enforceable upon them under any applicable law (other than Belgian law), and the exercise and performance by the Company and each
relevant Share Option Holder of its rights and obligations under the relevant Share Options is or will be lawful in any place of exercise
or performance (other than Belgium);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(t)</TD><TD STYLE="text-align: left">any factual circumstances, statements and matters set out in or implied by any of the documents referred
to in paragraph 3 (Documents Reviewed) are true, accurate and complete;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(u)</TD><TD STYLE="text-align: left">there are no provisions of the laws of any jurisdiction outside Belgium which would have any implication
for the opinion given in this Opinion Letter and, insofar as the laws of any jurisdiction outside Belgium may be relevant, such laws have
been or will be complied with;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(v)</TD><TD STYLE="text-align: left">for the purpose of the opinion referred to in paragraph 6 (Opinion) in so far as it relates to the actual
issuance of the New Shares to be issued upon exercise of the Share Options, (i) such Share Options have been or will be validly granted
to the initial beneficiaries of such grants in accordance with their respective terms and conditions and applicable laws, (ii) at the
moment of their exercise, such Share Options will be validly outstanding, will not have expired and will not have been cancelled in accordance
with their respective terms and conditions and applicable laws, (iii) such Share Options will be validly exercised in accordance with
their respective terms and conditions and applicable laws, (iv) the applicable exercise price of such Share Options and the issue price
of the New Shares underlying such Share Options will be duly and fully paid up, (v) the relevant underlying New Shares will be duly subscribed
for, (vi) the issuance of the relevant underlying New Shares and the corresponding capital increase will be duly recorded by means of
a notarial deed before a Belgian notary public as required by Belgian law, and (vii) such notarial deed and an excerpt therefrom will
be duly filed and registered as required by Belgian law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(w)</TD><TD STYLE="text-align: left">the undertakings and agreements contained in the Share Options and agreements pursuant to which such Share
Options are granted, subscribed for, or acquired are and will be duly performed and complied with by all parties thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(x)</TD><TD STYLE="text-align: left">the issuance of the Share Options, the Potential Issuance and the (other) transactions contemplated by
the Potential Issuance do not or will not require the publication of a prospectus in accordance with Regulation (EU) 2017/1129 of the
European Parliament and of the Council of June 14, 2017 on the prospectus to be published when securities are offered to the public or
admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended from time to time , and/or the Belgian act of
July 11, 2018 on the offering of investment instruments to the public and the admission of investment instruments to the trading on a
regulated market, as amended from time to time.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 35.45pt">6.</TD><TD STYLE="text-align: left">Opinion</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">Based upon and subject to the assumptions,
qualifications and limitations set out in this Opinion Letter, having regard to such legal considerations as we have deemed relevant,
and subject to any matters, documents or events not disclosed to us, we express the following opinion insofar as Belgian law is concerned:
the New Shares, when duly authorized and issued and fully paid up upon exercise of the relevant Share Options in accordance with the respective
terms and conditions of such Share Options will be validly issued, fully paid up and non-assessable (meaning that a holder of the relevant
New Shares will not by reason of merely being such a holder, be subject to assessment or calls by the Company or its creditors for further
payment on such securities).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt">7.</TD><TD STYLE="text-align: justify">Qualifications</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">The opinion expressed in this Opinion
Letter is subject to the following qualifications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left; text-indent: -35.45pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 35.45pt"><B>7.1</B></TD><TD STYLE="text-align: left"><B>Reliance on searches and enquiries</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">The searches and enquiries referred to
in paragraph 4 (Searches and Enquiries) may not be up-to-date and do not constitute conclusive evidence of the matters stated therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left; text-indent: -35.45pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 35.45pt"><B>7.2</B></TD><TD STYLE="text-align: left"><B>Construction of certain terms</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(a)</TD><TD STYLE="text-align: left">In this Opinion Letter Belgian legal concepts which are expressed in English are to be construed in accordance
with the Belgian legal concepts to which they refer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(b)</TD><TD STYLE="text-align: left">When used in paragraph 6 (Opinion), the terms &ldquo;legal&rdquo; and &ldquo;validly&rdquo; are references
to the legal character of the relevant obligation, and the terms &ldquo;binding&rdquo; and &ldquo;enforceable&rdquo; mean that the relevant
obligation or instrument is of a type and form enforced by Belgian courts. None of these means that such an obligation or instrument will
be enforced in accordance with its terms in every circumstance, and they are not to be construed as a prediction of the outcome of litigation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left; text-indent: -35.45pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 35.45pt"><B>7.3</B></TD><TD STYLE="text-align: left"><B>Excluded matters</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left">We do not express an opinion regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(a)</TD><TD STYLE="text-align: left">(i) any laws of any jurisdiction (including, but not limited to, Belgium and the European Union) imposing
economic or trade sanctions or similar restrictive measures or regarding anti-terrorism, anti-money laundering, anti-bribery or anti-tax
evasion measures, (ii) any regulations enacted, administered, imposed or enforced by any relevant sanctions authority or (iii) the extent,
scope, legality or enforceability of any person&rsquo;s obligation to comply with any of such laws or regulations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(b)</TD><TD STYLE="text-align: left">the admission to trading and listing of the New Shares on any market or other trading facility for securities;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(c)</TD><TD STYLE="text-align: left">the accuracy or completeness of any statements or warranties of fact set out in documents referred to
in paragraph 3 (Documents Reviewed) (except for the representations and warranties as to which we are expressing an opinion), which statements
and warranties we have not independently verified.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0"></TD><TD STYLE="text-align: left; width: 35.45pt">8.</TD><TD STYLE="text-align: left">Disclosure, Reliance and Liability</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left">This Opinion Letter is issued by Baker McKenzie BV/SRL, a Belgian limited liability company (<I>BV/SRL</I>),
and not by or on behalf of Baker &amp; McKenzie International (a Swiss <I>Verein</I>) (&ldquo;<B>BMI</B>&rdquo;) or any of its other member
or associated firms (together with BMI, the &ldquo;<B>Other Baker McKenzie Entities</B>&rdquo;). In this Opinion Letter the expressions
&ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo; and like expressions should be construed accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(b)</TD><TD STYLE="text-align: left">No Other Baker McKenzie Entity or any directors, shareholders, members, partners, lawyers, employees,
contractors or consultants of Baker McKenzie BV/SRL or any Other Baker McKenzie Entity will be liable (whether contractually or non-contractually)
to any person under or in connection with this Opinion Letter or in connection with the Potential Issuance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.45pt"></TD><TD STYLE="width: 35.45pt">(c)</TD><TD STYLE="text-align: left">This Opinion Letter may only be relied upon by the Company in connection with the Registration Statement.
This Opinion Letter is strictly limited to the matters stated in it and may not be read as extending by implication to any matters not
specifically referred to in it. Nothing in this Opinion Letter should be taken as expressing an opinion in respect of any representations
or warranties, or other information, contained in any document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(d)</TD><TD STYLE="text-align: left">We consent to the filing of this Opinion Letter as an exhibit to the Registration Statement and to the
reference to us in the Registration Statement. In giving this consent, we do not concede that we are within the category of persons whose
consent is required under Section 7 of the Securities Act or the rules and regulations of the SEC thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 70.9pt; text-align: left; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 35.45pt"></TD><TD STYLE="text-align: left; width: 35.45pt">(e)</TD><TD STYLE="text-align: left">This Opinion Letter may only be relied upon, and be disclosed, on condition that it is construed in accordance
with Belgian law and that any dispute arising out of or in connection with it is brought before a Belgian court.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"><IMG SRC="ea028411901ex5-1img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Yours faithfully,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-transform: uppercase; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left">BAKER McKENZIE BV/SRL</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-transform: uppercase; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: left">/s/ Michael Van Acker</TD><TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: left">/s/ Roel Meers</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Partner <BR>
Michael.VanAcker@bakermckenzie.com</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Partner<BR> Roel.Meers@bakermckenzie.com</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea028411901ex23-1.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; color: Black"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; color: Black"><B>Consent
of Independent Registered Public Accounting Firm</B> </FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">MDxHealth
SA</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">Herstal,
Belgium</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; color: Black; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">We
consent to the incorporation by reference of our report dated April 2, 2026 relating to the consolidated financial statements of MDxHealth
SA, which appear in MDxHealth SA&rsquo;s Annual Report on Form 20-F for the year ended December 31, 2025, as filed with SEC on April
3, 2026, in this Registration Statement on Form S-8.</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; color: Black; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black"><U STYLE="text-decoration: none">BDO
R&eacute;viseurs d&rsquo;Entreprises SRL</U></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black"><U STYLE="text-decoration: none">On
behalf of it, </U></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black"><U>/s/
Bert Kegels&#9;</U></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black">&nbsp;</FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black"><U STYLE="text-decoration: none">Zaventem,
Belgium </U></FONT></P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal; color: Black"><U STYLE="text-decoration: none">April
3, 2026</U></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea028411901ex-fee.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FA.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.4a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: e2c0f4752d19761bbc7b289770487967 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-8</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001872529</ix:nonNumeric>
      <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_004">Fees to be Paid</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001872529</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2026-03-30</xbrli:startDate>
          <xbrli:endDate>2026-03-30</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001872529</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2026-03-30</xbrli:startDate>
          <xbrli:endDate>2026-03-30</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-8</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">MDxHealth SA</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 16%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 18%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 7%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_009">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_010">Ordinary Shares, no par value per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_011">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">7,410,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">2.3336</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">17,291,976.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">2,388.03</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 17%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 25%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" id="fee_017" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">17,291,976.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" id="fee_018" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">2,388.03</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" id="fee_019" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">2,388.03</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_020">1a. Represents shares issuable under the Registrant&#8217;s May 2017 Stock Option Plan, 2019 Stock Option Plan, 2021 Share Option Plan, 2022 Share Option Plan, 2023 Share Option Plan, 2023 Share Option Plan, 2024 Share Option Plan and 2025 Share Option Plan.<br/><br/>1b. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement also covers such indeterminate number of additional Ordinary Shares of the Registrant as is necessary to eliminate any dilutive effect of any future share consolidation, share dividend or similar transaction.<br/><br/>1c. Proposed Maximum Offering Price Per Unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based on the average of the high and low prices for the Registrant&#8217;s Ordinary Shares on March 31, 2026, as reported on The Nasdaq Capital Market.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex028411901_ex5-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex028411901_ex5-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "_ B(# 2(  A$! Q$!_\0
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M-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,5E8+&6.U65V('8$[AD^^!3/^%J:Y_SZZ=_W[?\ ^+KG^M4SV_[ QO9?>O\
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M%C2?^O*'_P! %>'^(_\ D9]6_P"OV;_T,U[AX<_Y%C2?^O*'_P! %>'^(_\
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MUZ]7D/Q4_P"1GMO^O)?_ $-ZG$I*GH;9%*4L<G)WT?Z'#UZ7\)/^8Q_VQ_\
M9Z\TKTOX2?\ ,8_[8_\ L]<>'_B(^HSO_<9_+\T>ET445ZQ^<!1110 4444
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M>C[>7I^7H>(T5TVH> ?$6G^8WV+[3$F/WELP?=G'1?O'KZ=O3FLS_A'-<_Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA\_S9Z-\%_\ D<;O_L'O_P"C(Z]IU74K;1]*NM1NVVP6\9D;D G'0#) R3@
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M]@WI0JD6[(SJY7B*4'.=K+S*?Q.\&Z_XA\2VUWI5A]H@2S6)G\Z-,,'<XPS
M]"*XO_A5_C'_ * __DS#_P#%UZ'\0?B#JWA/7X+"PM[*2*2U68F='+;BSCLP
MX^45R?\ PNCQ'_SY:5_WZD_^+K.7)?4]?"2QZH0]G&/+;2[.O^%7A?6?#?\
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MV$9W\R(] ,L -IY/48 &<TU4BS"ME6)I*]KKR_RW/0Z***T/+"BBB@ HHHH
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MO#5IX4T1-.M7>0EC)-*_620@ MCL.  /0=SDGS[X)II@AU)Q*AU8L 8V W+
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M?#T:BP>+NU=1;7YH^4**^I/^$4\.?] #2O\ P#C_ ,*/^$4\.?\ 0 TK_P
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M ZT)7@T3B*BH9A";VDK?C_PQ\_5Z]\%M<A2.^T.:6))'D%Q;H<AI#MPX!Z'
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MPQ2)D':RH 1D<'D4J2:;N:9U6I5*<%"2>KV?D:5%%%;GS1\Y_%#_ )*+JO\
MVQ_]$I7(5ZEX\\!^)=:\::AJ&GZ;YUK+Y>R3SXUSB-5/!8'J#7.?\*O\8_\
M0'_\F8?_ (NN247=Z'W.%Q5"-""<U>RZKL>C?!?_ )$Z[_["#_\ HN.G_%CQ
M2VCZ(NDVDB"[U!667(#%(,8;C/!;. <'@-T(%7OACH.I^'O#5S::K;?9YWO&
ME5/,5\J409RI(Z@UYYXB\&^//$FMW&I7>E.3(Q$4;7<)$4>3M0?,.!GT&3D]
M2:U=U!)'BTXT:F/G4G)<J=]]]K'GE%=?_P *O\8_] ?_ ,F8?_BZ/^%7^,?^
M@/\ ^3,/_P 76/++L?1_7,/_ ,_%]Z.0HKK_ /A5_C'_ * __DS#_P#%T?\
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)Q_\ )?\ (__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ea028411901ex5-1img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028411901ex5-1img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P (D# 2(  A$! Q$!_\0
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M5:UCG=>=6->+EU5M?/H9GC70](G\66/ACPUIT45T6'VB569L$C..3T"Y8_\
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J1HVDZ:T&CQZG?R@_:A;*^R,@#IU/<_E775M':Q\]B5S3=5))2;V=S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 30, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001872529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">MDxHealth SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Mar. 30, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary Shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">7,410,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">2.3336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 17,291,976.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 2,388.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">1a. Represents shares issuable under the Registrant&#8217;s May 2017 Stock Option Plan, 2019 Stock Option Plan, 2021 Share Option Plan, 2022 Share Option Plan, 2023 Share Option Plan, 2023 Share Option Plan, 2024 Share Option Plan and 2025 Share Option Plan.<br/><br/>1b. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement also covers such indeterminate number of additional Ordinary Shares of the Registrant as is necessary to eliminate any dilutive effect of any future share consolidation, share dividend or similar transaction.<br/><br/>1c. Proposed Maximum Offering Price Per Unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based on the average of the high and low prices for the Registrant&#8217;s Ordinary Shares on March 31, 2026, as reported on The Nasdaq Capital Market.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 30, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 17,291,976.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">2,388.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 2,388.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea028411901ex-fee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea028411901ex-fee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea028411901ex-fee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea028411901ex-fee.htm">ea028411901ex-fee.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea028411901ex-fee.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea028411901ex-fee.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 18,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea028411901ex-fee.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-26-039834-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-039834-xbrl.zip
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MR"T#YX<$#<! E5DC3-BA7%[@(Q+DT8CO;@ #3OG32@4O1]@9@PJ2+Y3P_T]
ME\"?O57&10!\L0R2.>$\!9O0+HO!>Q#=(9#E#HB'W(N$PR71LF C!W3@@WUS
M6NBVQ="+HGTKHGD/B)I4F/0;.:4>QRH+5KPPF5G:9HSV(7S_$^]$L"GA6V7<
MG/ 9<^W?4$L! A0#%     @ 9V6#7+N%U<ZY"@  S#$  !4
M ( !     &5A,#(X-#$Q.3 Q97@M9F5E+FAT;5!+!08      0 ! $,   #L
%"@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea028411901ex-fee_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872529</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-30</startDate>
            <endDate>2026-03-30</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872529</identifier>
        </entity>
        <period>
            <startDate>2026-03-30</startDate>
            <endDate>2026-03-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001872529</dei:EntityCentralIndexKey>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_004">false</ffd:PrevslyPdFlg>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">MDxHealth SA</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_009">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_010">Ordinary Shares, no par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_011">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_012"
      unitRef="shares">7410000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="USD">2.3336</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">17291976.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">2388.03</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_017"
      unitRef="USD">17291976.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">2388.03</ffd:TtlFeeAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">2388.03</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_020">1a. Represents shares issuable under the Registrant&#x2019;s May 2017 Stock Option Plan, 2019 Stock Option Plan, 2021 Share Option Plan, 2022 Share Option Plan, 2023 Share Option Plan, 2023 Share Option Plan, 2024 Share Option Plan and 2025 Share Option Plan.&lt;br/&gt;&lt;br/&gt;1b. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement also covers such indeterminate number of additional Ordinary Shares of the Registrant as is necessary to eliminate any dilutive effect of any future share consolidation, share dividend or similar transaction.&lt;br/&gt;&lt;br/&gt;1c. Proposed Maximum Offering Price Per Unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based on the average of the high and low prices for the Registrant&#x2019;s Ordinary Shares on March 31, 2026, as reported on The Nasdaq Capital Market.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
